Effect of niacin on preβ-1 high-density lipoprotein levels in diabetes.
Pan
Jianqiu
J
Diabetes Research Center, Tustin, CA, USA.
Shilian
Parastou
P
Ishida
Brian
B
Wu
Xiaoshan
X
Kane
John P
JP
Malloy
Mary J
MJ
Charles
M Arthur
MA
D000368:Aged; D016632:Apolipoprotein A-I / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D005260:Female; D053442:High-Density Lipoproteins, Pre-beta / Q000097:blood*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D009525:Niacin / Q000627:therapeutic use*; D017035:Pravastatin / Q000627:therapeutic use; D012189:Retrospective Studies; D019821:Simvastatin / Q000627:therapeutic use
D016632:Apolipoprotein A-I; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D053442:High-Density Lipoproteins, Pre-beta; D000960:Hypolipidemic Agents; D008055:Lipids; D009525:Niacin; D019821:Simvastatin; D017035:Pravastatin